We are live on ! Find out more
E

Ergoteles Portfolio holdings

AUM $68.2M
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
+7.33%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
10 Year Est. Return
AUM
$4.36B
AUM Growth
+$1.15B
Cap. Flow
+$991M
Cap. Flow %
22.7%
Top 10 Hldgs %
14.65%
Holding
1,807
New
1,048
Increased
148
Reduced
170
Closed
353

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$66.5M
2
XOM icon
ExxonMobil
XOM
+$54.9M
3
AAPL icon
Apple
AAPL
+$52.1M
4
HMSY
HMS Holdings Corp.
HMSY
+$48.4M
5
ORCL icon
Oracle
ORCL
+$42.3M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 14.66%
3 Consumer Discretionary 14.56%
4 Financials 10.08%
5 Industrials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CORR
926
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
$395K 0.01%
+59,600
New +$381K
EVFM
927
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$395K 0.01%
+23,313
New +$442K
GRTX
928
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$393K 0.01%
+40,000
New +$325K
HWC icon
929
Hancock Whitney
HWC
$6.12B
$391K 0.01%
+8,800
New +$409K
ES icon
930
Eversource Energy
ES
$28.4B
$390K 0.01%
+4,855
New +$409K
SYNA icon
931
Synaptics
SYNA
$4.36B
$389K 0.01%
+2,500
New +$338K
DCI icon
932
Donaldson
DCI
$10.8B
$388K 0.01%
6,100
-8,844
-59% -$547K
PBIP
933
DELISTED
Prudential Bancorp, Inc.
PBIP
$386K 0.01%
+27,887
New +$389K
AXSM icon
934
Axsome Therapeutics
AXSM
$12.3B
$385K 0.01%
5,700
-2,700
-32% -$162K
JLL icon
935
Jones Lang LaSalle
JLL
$15.4B
$384K 0.01%
+1,966
New +$384K
MRKR icon
936
Marker Therapeutics
MRKR
$20.7M
$383K 0.01%
+13,740
New +$362K
SBFG icon
937
SB Financial Group
SBFG
$165M
$383K 0.01%
+21,735
New +$384K
EARN
938
Ellington Residential Mortgage REIT
EARN
$168M
$381K 0.01%
+32,400
New +$401K
PAYS icon
939
Paysign
PAYS
$495M
$381K 0.01%
+119,909
New +$431K
GNE icon
940
Genie Energy
GNE
$382M
$380K 0.01%
+60,200
New +$369K
CTLT
941
DELISTED
CATALENT, INC.
CTLT
$380K 0.01%
+3,514
New +$377K
NEXT icon
942
NextDecade
NEXT
$1.77B
$379K 0.01%
+91,700
New +$259K
AYTU icon
943
AYTU BioPharma
AYTU
$23.5M
$378K 0.01%
+3,774
New +$443K
EYE icon
944
National Vision
EYE
$1.66B
$378K 0.01%
+7,400
New +$363K
LMST
945
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
$378K 0.01%
+22,700
New +$363K
EPAY
946
DELISTED
Bottomline Technologies Inc
EPAY
$378K 0.01%
+10,200
New +$420K
FWRD icon
947
Forward Air
FWRD
$487M
$377K 0.01%
4,200
-3,200
-43% -$295K
NOVT icon
948
Novanta
NOVT
$5B
$377K 0.01%
+2,800
New +$377K
ORGS
949
DELISTED
Orgenesis Inc. Common Stock
ORGS
$377K 0.01%
+7,432
New +$374K
ADEA icon
950
Adeia
ADEA
$2.8B
$376K 0.01%
+63,984
New +$364K

Similar funds

Ergoteles's Q2 2021 Portfolio in Review

As of Q2 2021, Ergoteles held 1,807 positions worth $4.36B, up 36% from $3.21B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Ergoteles deployed $991M of net new capital in Q2 2021, opening 1,048 new positions and adding to 148 existing holdings. Its largest new stake was Linde: 174,841 shares worth $50.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Walt Disney, an estimated $66.5M trimmed.

  • Ergoteles's largest Q2 2021 buy was Linde: 174,841 shares worth $50.5M.
  • Ergoteles added most to PRA Health Sciences, Inc. in Q2 2021, an estimated $160M increase.
  • Ergoteles's biggest Q2 2021 reduction was Walt Disney, cutting an estimated $66.5M.
  • Ergoteles fully exited ExxonMobil in Q2 2021, selling an estimated $54.9M.
  • Ergoteles's ten largest holdings make up 15% of its $4.36B portfolio in Q2 2021.
  • Ergoteles opened 1,048 new positions and closed 353 in Q2 2021.
  • Ergoteles's portfolio value rose 36% quarter-over-quarter to $4.36B.

Based on Ergoteles's 13F filing for Q2 2021, filed 12 Aug 2021.